Skip to main content

Table 4 Clinically relevant decrease (CRD) in EPIC urinary and bowel domains

From: A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

Group

    Urinary domain

 

    Bowel domain

 

Month

Month

Month

Month

Month

Month

 

1

2

3

1

2

3

Arm 1

40%

59%

37%

53%

48%

29%

Arm 2

57%

54%

20%

66%

61%

28%

t-test

p = 0.045

NS

p = 0.002

NS

NS

NS

  1. Abbreviations: Arm 1 = conventional fractionation; Arm 2 = hypofractionation; NS = difference not significant (p < 0.05).
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us